France’s Sanofi and the UK’s Glaxo-SmithKline (GSK) yesterday said they would test their potential COVID-19 vaccine further after clinical trials showed an insufficient immune response in older people, delaying its potential launch until the end of next year.
The two companies said they planned to start another study in February, hoping to come up with a more effective vaccine by the end of next year, in a blow to efforts to fight the COVID-19 pandemic.
The news comes as a disappointment for one of a crop of vaccines under development that rely on more conventional proven designs as the shot developed by Pfizer and BioNTech using breakthrough technology gets rolled out across Britain.
It is also a blow for many governments, including the EU, the US, Canada and Britain, which have booked hundreds of millions of doses of the shot as they struggle to tame the virus, which has killed more than 1.5 million people and crushed economies.
Delays and additional trials are not unusual, but the setback highlights the challenges in developing vaccines at record speed.
It also underscores why governments have booked lots of different shots so they are not replying on just one.
Yesterday’s results showed “an immune response comparable to patients who recovered from COVID-19 in adults aged 18 to 49 years, but a low immune response in older adults likely due to an insufficient concentration of the antigen,” Sanofi said.
“With this type of vaccine, the result is not a surprise, we know that more antigen is needed in older patients. But when in phase I and II, drugmakers test tolerance and one cannot test strong dosages,” said Jean-Daniel Lelievre, head of clinic immunology and infectious diseases at Henri-Mondor hospital in Creteil, France.
“I would think Sanofi and GSK will be able to improve their vaccine,” he said.
Phase III studies were expected to start this month.
Sanofi said it would launch a phase 2b study in February instead after a recent challenge study in non-human primates performed with an improved antigen formulation demonstrated better effects.
“The study will include a proposed comparison with an authorized COVID-19 vaccine,” the company said.
“If data are positive, a global Phase III study could start in Q2 2021. Positive results from this study would lead to regulatory submissions in the second half of 2021, hence delaying the vaccine’s potential availability from mid-2021 to Q4 2021,” it said.
The two companies said they had “updated governments and the European Commission where a contractual commitment to purchase the vaccine has been made.”
The Sanofi-GSK vaccine uses the same recombinant protein-based technology as one of Sanofi’s seasonal influenza vaccines. It would be coupled with an adjuvant, a substance that acts as a booster to the vaccine, made by GSK.
The Phase I/II study tested the safety, tolerability and immune response of the vaccine in 440 healthy adults across 11 investigational sites in the US.
This week, Britain started deploying a vaccine that uses a breakthrough mRNA technology developed by Pfizer and BioNTech, jumping ahead of the rest of the world in the race. Canada gave the greenlight for the shot, too.
The data comes as a panel of outside advisers to the US Food and Drug Administration on Thursday voted overwhelmingly to endorse emergency use of the Pfizer/BioNTech vaccine.
Sanofi and GSK have scaled up manufacturing to be ready to produce up to 1 billion doses of their vaccine next year.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”